ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000251141.1	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.048834209	Resistant
ENSG00000251141.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.048019728	Sensitive